Barrier.bio

Curated by Signal

AI-powered drug discovery platform for neurological diseases

Overview

AI-powered drug discovery platform for neurological diseases. The company is creating medicines with the application of spatial biology and AI to cross barriers and deliver breakthrough science for neurological diseases and disorders.

Key facts

Founded: 2022
Headquarters: Los Angeles, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Convoke
Provider of AI-based platform to automate data collection, synthesis, and analysis for biotech and pharmaceutical companies
Health TechnologySan Francisco, United States
Lilu Farms
Provider of cannabis-derived nutritional and wellness products
Health TechnologyBeaufort, United States
Cyrano
Digital telecommunication system for healthcare professionals
Health TechnologyAtlanta, United States

About Barrier.bio

What does Barrier.bio do?

AI-powered drug discovery platform for neurological diseases.

Where is Barrier.bio headquartered?

Barrier.bio is headquartered in Los Angeles, United States.

When was Barrier.bio founded?

Barrier.bio was founded in 2022.

Which sector is Barrier.bio in?

Barrier.bio operates in Health Technology.

Who are Barrier.bio's competitors?

Companies similar to Barrier.bio include Convoke, Lilu Farms, and Cyrano.